<DOC>
	<DOCNO>NCT01128426</DOCNO>
	<brief_summary>The purpose study expand understand safety profile 13vPnC routine use follow licensure introduction vaccine .</brief_summary>
	<brief_title>Postlicensure Observational Safety Study 13vPnC Administered Infants Toddlers</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Infants start vaccination 13vPnC first 6 month life member Northern California Kaiser Permanente healthcase system receive least 1 dose 13vPnC study observation period include . Infants must 7vPnC time 13vPnC dose administration . Infants child previously vaccinate number dos 7vPnC exclude .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Pneumococcal conjugate vaccine</keyword>
</DOC>